Skip to main content
Signal8

Hutson Nancy J

SEC insider (Form 3/4/5 filer). CIK 0001379222. Director at BIOCRYST PHARMACEUTICALS INC (BCRX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2025. Located in DURHAM, NC.

Companies Hutson Nancy J has filed insider reports for

  • BIOCRYST PHARMACEUTICALS INC (BCRX): Director
Hutson Nancy J profile photo

Hutson Nancy J

CIK: 0001379222

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIOCRYST PHARMACEUTICALS INC logo
BCRX

BIOCRYST PHARMACEUTICALS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • BIOCRYST PHARMACEUTICALS INC logo
    BCRX

    BIOCRYST PHARMACEUTICALS INC

    Jun 12, 2025
    Award
    Direct
    12.5K shares-
  • BIOCRYST PHARMACEUTICALS INC logo
    BCRX

    BIOCRYST PHARMACEUTICALS INC

    Dec 13, 2024
    Sale
    Direct
    7K shares at avg. $7.54$53K

1-2 of 2